IDEV adds Donohoe for industry expertise
This article was originally published in Clinica
Minimally-invasive medical device manufacturer IDEV Technologies has made industry veteran Dennis Donohoe its chief medical officer. Dr Donohoe has previously worked in a range of positions for Johnson & Johnson (where he spent 20 years), Ethicon, Glaxo and McNeil Pharmaceuticals. He will lend IDEV particular expertise in clinical trials and regulatory affairs. Webster, Texas-based IDEV specialises in developing devices designed for endovascular interventional use. The firm’s lead product is the self-expanding nitinol Supera stent.